Compare Extra Space Storage, Inc. (EXR) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Extra Space Storage, Inc. vs TransMedics Group Inc — how do they compare? Extra Space Storage, Inc. trades at $134.65 (market cap $28.12B), while TransMedics Group Inc trades at $77.87 (market cap $2.74B). The key difference: Extra Space Storage, Inc. is far larger — about 10.3× TransMedics Group Inc's market cap, and Extra Space Storage, Inc. pays a 4.87% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Extra Space Storage, Inc. for 109 Days and TransMedics Group Inc for 24 Days on average.
| EXR | TMDX | |
|---|---|---|
Market Cap | $28.12B | $2.74B |
Volume | 2,595,579 | 949,331 |
Sector | Real Estate | Health |
52-Week High | $152.85 | $150.42 |
52-Week Low | $126.67 | $61.99 |
Typical Hold Time | 109 Days | 24 Days |
Enterprise Value | $41.84B | $3.13B |
Dividend Yield | 4.87% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Extra Space Storage (EXR) trades at $133.12, up 1.08% on the day, with a mixed technical picture showing bearish moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q3 2026 results expected soon. Revenue grew to $3.38 billion in 2025, and net income margin remains healthy at 27.79%. Analyst consensus is evenly split between Buy and Hold, with a price target of $158.33 implying upside potential. Recent news highlights leadership transition and institutional buying interest.
EXR presents a balanced risk-reward profile. Upside is supported by steady demand, dividend payments, and analyst targets, but risks include high leverage, interest rate sensitivity, and a bearish technical trend. The stock's valuation multiples are elevated, requiring sustained earnings growth to justify current levels. Investors should weigh solid fundamentals against macroeconomic headwinds affecting REITs.
TMDX trades at $79.00, down 2.55% amid bearish technical signals. The stock shows strong profitability with 22.69% net margin and 36.28% ROE, though recent earnings misses and margin compression from 2025 to 2026 raise concerns. Analyst consensus remains bullish with a $99.75 price target, but multiple legal investigations into fiduciary duties create uncertainty. Revenue growth continues with 2026 guidance at $668M.
The stock presents a growth opportunity with analyst upside potential, but faces near-term headwinds from earnings volatility and legal scrutiny. Execution on 2026 guidance and resolution of governance concerns will be critical for sustained momentum. Current valuation at 20.47 P/E appears reasonable given growth prospects if operational targets are met.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Extra Space Storage, Inc.
Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages almost 2,100 self-storage properties in 41 states, with over 160 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.
Read more on EXR →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
